|

Darolutamide intermittent Clinical Trials

1 actively recruiting trial

Also known as: Darolutamide

Pipeline

Phase 3: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Intermitent Anti-androgen Therapy1
  • Metastatic Prostate Cancer1
  • Cancer1

Other1 trial

Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.